Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5035.00    -30.00 (-0.59%)
Bid:
5020.00
Ask:
5035.00
Spread: 15.00 (0.299%)
Market Cap: £3.66b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Form 8.3 - Renishaw PLC

19 Apr 2021 11:19

RNS Number : 8961V
Baillie Gifford & Co.
19 April 2021
Β 

FORMΒ 8.3

Β 

PUBLICΒ OPENINGΒ POSITIONΒ DISCLOSURE/DEALINGΒ DISCLOSUREΒ BY

AΒ PERSONΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β OR MORE

RuleΒ 8.3Β ofΒ theΒ TakeoverΒ CodeΒ (theΒ "Code")

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Renishaw Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

Β 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16 April 2021

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevant securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ in 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (as appropriate)Β for eachΒ additionalΒ classΒ of relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offeree toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealingΒ (ifΒ any)

Β 

Class of relevant security:

20p Ordinary

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

4,990,469

6.86

Β 

Β 

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

TOTAL:

4,990,469

6.86

Β 

Β 

Β 

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ be disclosed.

Β 

Details Β of Β any Β open Β stock-settled Β derivative Β positions Β (including Β traded Β options), Β or agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ Supplemental FormΒ 8Β (OpenΒ Positions).

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employee options)

Β 

Class of relevant security in relation to

which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. Β DEALINGSΒ (IFΒ ANY)Β BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ have beenΒ dealingsΒ in moreΒ than oneΒ classΒ of relevantΒ securitiesΒ of theΒ offerorΒ or offeree named inΒ 1(c), copyΒ table 3(a), (b), (c)Β orΒ (d)Β (asΒ appropriate)Β forΒ each additionalΒ class ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) Β PurchasesΒ andΒ sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

20p Ordinary

Sale

1,331

64.218

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Β 

Β 

Β 

Β 

Β 

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercise

Β 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Β 

DetailsΒ ofΒ anyΒ indemnityΒ orΒ optionΒ arrangement,Β orΒ anyΒ agreementΒ orΒ understanding, formalΒ orΒ informal,Β relatingΒ toΒ relevantΒ securitiesΒ whichΒ mayΒ beΒ anΒ inducementΒ toΒ deal orΒ refrainΒ fromΒ dealingΒ enteredΒ intoΒ byΒ theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ party toΒ theΒ offerΒ orΒ anyΒ personΒ actingΒ inΒ concertΒ withΒ aΒ partyΒ toΒ theΒ offer:

IrrevocableΒ commitmentsΒ andΒ lettersΒ of intentΒ shouldΒ notΒ be included.Β IfΒ thereΒ areΒ noΒ such agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

None

Β 

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

DetailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understanding,Β formalΒ orΒ informal,Β between theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ otherΒ personΒ relatingΒ to:

(i)Β theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option;Β or

(ii)Β theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ which anyΒ derivativeΒ isΒ referenced:

IfΒ thereΒ areΒ noΒ suchΒ agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

Β 

None

Β 

Β 

(c) Attachments

Β 

IsΒ aΒ SupplementalΒ FormΒ 8 (OpenΒ Positions)Β attached? NO

Β 

Β 

Β 

Date of disclosure:

19.04.2021

Contact name:

Grant Meikle

Telephone number:

0131 275 3134

Β 

PublicΒ disclosuresΒ underΒ RuleΒ 8Β ofΒ theΒ CodeΒ mustΒ beΒ madeΒ toΒ aΒ RegulatoryΒ Information

Service.

Β 

TheΒ Panel'sΒ MarketΒ SurveillanceΒ UnitΒ isΒ availableΒ forΒ consultationΒ inΒ relationΒ toΒ theΒ Code's disclosureΒ requirementsΒ on +44Β (0)20Β 7638Β 0129.

Β 

TheΒ CodeΒ canΒ be viewedΒ onΒ the Panel'sΒ websiteΒ atΒ Β www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETSFWFSUEFSEFL
Date   Source Headline
12th Jul 20232:30 pmRNSVoting Arrangement
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.